Integrating sex as a biological variable in clinical research represents a crucial advancement for improving scientific rigor and health equity. Understanding and accounting for Sex differences in health outcomes, disease progression, and treatment responses are fundamental to advancing equitable healthcare and scientific rigor. Differences in disease manifestation, symptom presentation, and therapeutic responses between males and females have been extensively documented. However, these differences are often under-addressed in research, leading to biases in findings and limited applicability of results to all populations.

The NIH’s Sex as a Biological Variable (SABV) [1] policy provides the foundation for addressing these disparities. SABV emphasizes the consideration of Sex throughout all stages of the research lifecycle, from the design and implementation of studies to data analysis and dissemination of results [2]. By integrating Sex as a core variable, as well as Gender as an additional variable of interest, researchers can better capture the biological and sociocultural determinants of health and produce findings that are generalizable and clinically meaningful. However, this document focuses primarily on the statistical implementation of Sex as a Biological Variable (SABV), with gender considerations incorporated where they intersect with accurate measurement of biological sex.

This policy aligns with mandates such as the 21st Century Cures Act and Executive Order 14120, enacted in December 2016, which prioritize the advancement of women's health and systemic equity in medical research. Specifically, the act mandates that Applicable Phase III clinical trials report their results in ClinicalTrials.gov by sex and by race and ethnicity [3]. The NIH SABV initiative also builds on existing efforts to improve the accuracy and inclusivity of health science, ensuring that health policies and interventions are evidence-based and inclusive of Sex-specific considerations [4]

This document, developed during the author’s tenure at the Biostatistics and Clinical Epidemiology Service (CC-BCES) of the NIH Clinical Center, outlines a framework of progressive statistical considerations for Sex inclusion in clinical studies. It is structured around the 4Cs framework: Consider, Collect, Characterize, Communicate. This framework guides researchers through all stages of integrating Sex into their research, supported by illustrative examples, best practices, and advanced methodologies. These guidelines aim to bridge existing gaps and promote equitable healthcare outcomes for all Sexes.